Detalhe da pesquisa
1.
Plasma Cell-Free DNA Is a Potential Biomarker for Diagnosis of Calcific Aortic Valve Disease.
Cardiology
; 149(2): 155-162, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-37899036
2.
HNRNPA2B1-Mediated MicroRNA-92a Upregulation and Section Acts as a Promising Noninvasive Diagnostic Biomarker in Colorectal Cancer.
Cancers (Basel)
; 15(4)2023 Feb 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36831695
3.
Ferroptosis Associates With Diagnosis and Prognosis by Promoting Antitumor Immune Response in Melanoma.
Front Cell Dev Biol
; 10: 915198, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35874826
4.
Pyroptosis correlates with tumor immunity and prognosis.
Commun Biol
; 5(1): 917, 2022 09 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36068291
5.
Plasma Cell-Free DNA as a Novel Biomarker for the Diagnosis and Monitoring of Atherosclerosis.
Cells
; 11(20)2022 10 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36291116
6.
m6A modification promotes miR-133a repression during cardiac development and hypertrophy via IGF2BP2.
Cell Death Discov
; 7(1): 157, 2021 Jun 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34226535
7.
HNRNPA2B1 Affects the Prognosis of Esophageal Cancer by Regulating the miR-17-92 Cluster.
Front Cell Dev Biol
; 9: 658642, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34277606
8.
YTHDF1 Promotes Cyclin B1 Translation through m6A Modulation and Contributes to the Poor Prognosis of Lung Adenocarcinoma with KRAS/TP53 Co-Mutation.
Cells
; 10(7)2021 07 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34359836